Avanzanite
Avanzanite Bioscience B.V. | No One Left Behind
Amsterdam, Netherlands · Founded 2022 · $37.0M raised
- Headquarters
- Amsterdam
- Founded
- 2022
- Business Model
- B2B
- Website
- avanzanite.com
- Total Funding
- $37.0M
- Last Round
- $37.0M Series ANov 2025
- Rounds
- 1
About
Healthcare portfolio company
Summary
Avanzanite is a Biotech company based in Amsterdam, Netherlands, founded in 2022. It has raised $37.0M in total across 1 round, most recently a $37.0M Series A round in Nov 2025. Investors include MVM Partners.
Tech & App Stack
1 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2025
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.